GM, A., RE, E., AA, M., OM, H., AR, A. (2010). HEPATITIS B VIRAL MARKERS AND VACCINATION STATUS AMONG HEALTH CARE PROVIDERS IN MENOUFIA GOVERNORATE. Egyptian Journal of Occupational Medicine, 34(2), 267-279. doi: 10.21608/ejom.2010.726
Abdel Rasoul GM; El Bahnasy RE; Michael AA; Hendy OM; Ahmed AR. "HEPATITIS B VIRAL MARKERS AND VACCINATION STATUS AMONG HEALTH CARE PROVIDERS IN MENOUFIA GOVERNORATE". Egyptian Journal of Occupational Medicine, 34, 2, 2010, 267-279. doi: 10.21608/ejom.2010.726
GM, A., RE, E., AA, M., OM, H., AR, A. (2010). 'HEPATITIS B VIRAL MARKERS AND VACCINATION STATUS AMONG HEALTH CARE PROVIDERS IN MENOUFIA GOVERNORATE', Egyptian Journal of Occupational Medicine, 34(2), pp. 267-279. doi: 10.21608/ejom.2010.726
GM, A., RE, E., AA, M., OM, H., AR, A. HEPATITIS B VIRAL MARKERS AND VACCINATION STATUS AMONG HEALTH CARE PROVIDERS IN MENOUFIA GOVERNORATE. Egyptian Journal of Occupational Medicine, 2010; 34(2): 267-279. doi: 10.21608/ejom.2010.726
HEPATITIS B VIRAL MARKERS AND VACCINATION STATUS AMONG HEALTH CARE PROVIDERS IN MENOUFIA GOVERNORATE
1Departemt of Public Health and Community Medicine, Faculty of Medicine, Menoufia University,
2Department of Clinical Pathology, National Liver Institute, Menoufia University
3Department of Environmental Health, National Liver Institute, Menoufia University
Abstract
Objectives: this study aimed at determinination of HBV viral markers, vaccination status of physicians and nurses acting in high risk departments and to estimate anti- HBs titer in vaccinated persons. Subjects and methods: A cross sectional study was done for doctors and nurses in high-risk departments in a district hospital in Menoufiya Governorate selected by simple random sampling. One hundred health care workers (HCWs) voluntarily participated in the study. A structured questionnaire was used to collect demographic data, HBV vaccination history and occupational risk factors. ELISA was used to test sera for HBsAg, Anti-HBs and total anti-HBc. Results: among the 100 participants, none of them tested positive for HBsAg, 49% had Anti-HBs, and 26% had Anti-HBc. Only 29% of the HCWs were immune after vaccination although 34% reported complete three doses HBV vaccine. Forty five of HCWs (45%) never vaccinated and were susceptible to HBV infection. The prevalence of life time exposure to HBV was 26%. All who reported complete vaccination had HBsAb, pyears (149.48± 43.67 vs. 97.47±29.25), in those who are free from chronic diseases (144.77± 45.70 vs. 102.08±31.01), and among those who had last dose of vaccine exposure factor. There is a need to vaccinate all HCWs as a matter of policy.